20 Mar 2023 | Participate, Unclassified
Call for applications for the position of Director of the Cancer Research Center of Toulouse (CRCT) Inserm, the University of Toulouse III Paul Sabatier and the CNRS are opening a call for applications for the position of Director of the Cancer Research Center of...
2 Dec 2022 | Unclassified
Biolican : To develop new technological approaches for the detection of new circulating biomarkers for the management of lung cancer. In routine clinical practice, physicians rely heavily on tumour biopsy to make a diagnosis of cancer. This tumour sample also...
28 Nov 2022 | Unclassified
LungPredict A collaboration in Toulouse, France, between Pierre Fabre Research Institute, the University Cancer Institute and the Cancer Research Center aims to collect and integrate data to improve and personalize lung cancer therapies. The ultimate goal of the...
24 Nov 2022 | Unclassified
MSrGB: Metabolic Shift in radioresistance of GlioBlastoma Study of the involvement of metabolic shift in the radioresistance of glioblastoma stem cells: validation on blood samples and metabolic imaging of patients treated for glioblastoma in primary diagnosis...
5 Oct 2022 | Unclassified
BLOOD-REPARP: Circulating biomarkers of resistance to PARP inhibitors in HER2-negative metastatic breast cancer. PARP inhibitors improve progression free survival compared to standard chemotherapy ofHER2-negativemetastaticbreast cancer (mBC) patients bearing germline...
30 Sep 2022 | Unclassified
CIRComa : Deciphering the role of circular RNAs in the pathogenesis and therapeutic resistance of anaplastic large cell lymphomas associated with the oncogenic tyrosine kinase ALK. Deciphering the role of circular RNAs in the pathogenesis and therapeutic resistance of...
